Communiqués Asahi Kasei Corporation

Actions

3407

JP3111200006

Chimie diversifiée

Temps Différé Japan Exchange Autres places de cotation 07:19:31 05/08/2026			Varia. 5j.	Varia. 1 janv.
1 623,50 ^JPY	+2,79%		-11,25%	+16,95%

31/07	Asahi Kasei : le bénéfice net bondit de 173 % au premier trimestre fiscal	MT
31/07	Asahi Kasei Corporation annonce ses prévisions de dividende pour la fin du deuxième trimestre de l'exercice clos le 31 mars 2027	CI

Communiqués

03/08	Asahi Kasei : Notice regarding status of share repurchase	PU
31/07	Asahi Kasei : Financial Results Presentation Material, first quarter fiscal 2026	PU
15/07	Asahi Kasei Microdevices Begins Mass Production of Camera‑less Modules for Detection of Falls, Vital Signs, Posture, and Position	BU
08/07	Asahi Kasei : Home Order Trends – June 2026	PU
07/07	Asahi Kasei Adds New Slitting Facility for SUNFORT™ to Meet Growing Demand for Advanced Semiconductor Packaging	BU
01/07	Asahi Kasei : Notice regarding status of share repurchase	PU
30/06	Asahi Kasei : obtains exclusive distribution rights for additional indications of Empaveli™	PU
26/06	Asahi Kasei's Novel Forward Osmosis-Membrane Distillation System Installed at Peptistar's API Manufacturing Facility for Reduced Pharmaceutical Manufacturing Time	AQ
25/06	Asahi Kasei’s Novel Forward Osmosis–Membrane Distillation System Installed at Peptistar's API Manufacturing Facility for Reduced Pharmaceutical Manufacturing Time	BU
25/06	Asahi Kasei : novel forward osmosis–membrane distillation system installed at Peptistar's API manufacturing facility for reduced pharmaceutical manufacturing time	PU
24/06	Asahi Kasei : Results of Vote at the 135th Ordinary General Meeting of Shareholders	PU
03/06	EAS Batteries Starts Sales of Ultra-High-Power Cell Using Asahi Kasei's Novel Electrolyte Acetolyte	AQ
02/06	EAS Batteries Starts Sales of Ultra-High-Power Cell Using Asahi Kasei’s Novel Electrolyte Acetolyte™	BU
29/05	ZOLL(R) Expands 'Anything Can Happen. Anyone Can Help.' to Strengthen Cardiac Emergency Readiness Across Youth Sports Nationwide	AQ
28/05	Asahi Kasei Life Science Acquires License for Novel Antibody-Drug Conjugate Technology from The Noguchi Institute - A Major Milestone for More Efficient and Safer Cancer Treatments	AQ
27/05	Asahi Kasei Life Science Acquires License for Novel Antibody-Drug Conjugate Technology from The Noguchi Institute – A Major Milestone for More Efficient and Safer Cancer Treatments	BU
21/05	Asahi Kasei Develops Novel Photosensitive Polyimide Film for Advanced Panel-Level Semiconductor Packaging	BU
20/05	Asahi Kasei Microdevices Debuts AK491x Premium Audio Op Amps at HIGH END Vienna 2026	BU
18/05	Asahi Kasei : Teijin Frontier and Asahi Kasei Advance Announce New Company Name Ahead of Planned Business Integration	PU
18/05	Asahi Kasei : Begins Phase III Clinical Trial of Teriparatide Acetate for Patients with Osteoporosis at High Risk of Fracture	PU
12/05	Asahi Kasei Optimizes Material Portfolio Through Supply Realignment by FY2030	BU
12/05	Asahi Kasei : Financial Summary (mar2026)	PU
12/05	Asahi Kasei : Notice of payment of dividends from surplus (increased dividend) and forecast of dividends (e260512)	PU
12/05	Asahi Kasei : Presentation Material (2603supplement)	PU
12/05	Asahi Kasei : (Press Release) Asahi Kasei Optimizes Material Portfolio Through Supply Realignment by FY2030 (e260512 2)	PU